OPB-171775   Click here for help

GtoPdb Ligand ID: 13643

Synonyms: Example 124 [US20190023662] [2] | OPB171775
Compound class: Synthetic organic
Comment: OPB-171775 is a molecular glue [3]. Structurally it is a PDE3A inhibitor derivative. In gastrointestinal stromal tumour cells it promotes formation of a ternary complex with phosphodiesterase 3A (PDE3A) and schlafen family member 12 (SLFN12). PDE3A/SLFN12 complex formation activates the pro-apoptotic ribonuclease activity of SLFN12, which results in a cytotoxic antitumour effect [1]. This molecular mechanism is proposed as an alternative to tyrosine kinase inhibitor (TKI)-based cancer therapies, particularly for TKI-resistant tumours.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 70.92
Molecular weight 312.31
XLogP 1.55
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@@H]1CC(=O)NN=C1C2=C(C(=C(C=C2)OCC(C)(C)O)F)F
Isomeric SMILES C[C@@H]1CC(=O)NN=C1C2=C(C(=C(C=C2)OCC(C)(C)O)F)F
InChI InChI=1S/C15H18F2N2O3/c1-8-6-11(20)18-19-14(8)9-4-5-10(13(17)12(9)16)22-7-15(2,3)21/h4-5,8,21H,6-7H2,1-3H3,(H,18,20)/t8-/m1/s1
InChI Key GGUTYKLJESECBW-MRVPVSSYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. de Waal L, Lewis TA, Rees MG, Tsherniak A, Wu X, Choi PS, Gechijian L, Hartigan C, Faloon PW, Hickey MJ et al.. (2016)
Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics.
Nat Chem Biol, 12 (2): 102-8. [PMID:26656089]
2. Katoh T, Iida M, Terauchi Y, Yamaguchi K, Hirose T, Yokoyama F, Nishimori H, Obuchi Y, Nabeshima H, Takaki E. (2019)
5-methyl-6-phenyl-4,5-dihydro-2h-pyridazin-3-one derivative.
Patent number: US20190023662A1. Assignee: Otsuka Pharmaceutical Co Ltd. Priority date: 02/03/2017. Publication date: 24/01/2019.
3. Takaki EO, Kiyono K, Obuchi Y, Yamauchi T, Watanabe T, Matsumoto H, Karimine M, Kuniyoshi Y, Nishikori S, Yokoyama F et al.. (2024)
A PDE3A-SLFN12 Molecular Glue Exhibits Significant Antitumor Activity in TKI-Resistant Gastrointestinal Stromal Tumors.
Clin Cancer Res, 30 (16): 3603-3621. [PMID:38864850]